Brachytherapy using strontium-90 is now being used in conjunction with other therapies in an attempt to treat Age-related Macular Degeneration, the leading cause of vision loss and blindness in adults, in the CABERNET study. Medical writer Ajay Malik, PhD, reviews the studies involved.
The investigational radioisotope, F-18 FLT (fluorothymidine), is showing promise in clinical trials in the ability to assess response to cancer treatment. Research into the clinical applications of the FLT radiotracer has been underway for over 10 years. After FDA approval for use in clinical trials, the molecular imaging community is holding much promise in the